Skip to main content

Table 1 Baseline characteristics

From: Assessment of long-term quality of life after cavotricuspid isthmus ablation for typical atrial flutter

Age (years), mean (SD) 64.4 (10.6)
Men, n (%) 77 (81.9)
Smokers, n (%) 45 (47.9)
Alcohol, n (%) 12 (12.8)
Obesity, n (%) 24 (25.5)
Hypertension, n (%) 46 (48.9)
Diabetes mellitus, n (%) 19 (20.2)
Hyperlipidemia, n (%) 40 (42.6)
Renal failure, n (%) 8 (8.5)
Ischemic heart disease, n (%) 14 (14.9)
Myocardial infarction, n (%) 10 (10.6)
CABG*, n (%) 12 (12.8)
Heart failure, n (%) 18 (19.1)
Dilated cardiomyopathy, n (%) 21 (22.3)
Tachycardiomyopathy, n (%) 17 (18.1)
Valvular heart disease, n (%) 19 (20.2)
  - Aortic stenosis 4 (4.3)
  - Mitral regurgitation 12 (12.8)
  - Tricuspid regurgitation 3 (3.2)
Pacemaker, n (%) 7 (7.4)
Atrial fibrillation, n (%) 41 (43.6)
COPD†, n (%) 20 (21.3)
Asthma, n (%) 5 (5.3)
Steinert, n (%) 2 (2.1)
Arthrosis, n (%) 23 (24.5)
Oral anticoagulation, n (%) 55 (58.5)
Antiarrhythmic drugs, n (%) 47 (50.0)
Betablockers, n (%) 15 (16.0)
Verapamil/diltiazem, n (%) 21 (22.3)
Digoxin, n (%) 12 (12.8)
  1. *CABG: Coronary Artery Bypass Graft. COPD: Chronic Obstructive Pulmonary Disease.